Personalis in Partnership with BC Cancer to Assess Clinical and Economic Benefits of ctDNA for Colorectal and Pancreatic Cancers
Personalis’ Next Personal™ liquid biopsy assay will be deployed in study collaboration
News
Ly Vu awarded Michael Smith Health Research BC Scholar Award
Ly Vu has been awarded the Michael Smith Health Research BC Scholar Award for the project titled, "Post-transcriptional regulation of hematopoietic stem cell function during normal and malignant hematopoiesis."
The Michael Smith Health Research BC Scholar Program supports early-career health researchers who are building leading-edge health research programs, training the next generation of scientists and expanding their potential to make significant contributions to their field.
BC Cancer researchers part of international collaboration to develop treatments for osteosarcoma
BC Cancer researchers are playing a central role in a new international collaboration aimed at developing innovative treatments for osteosarcoma — a highly malignant bone cancer that commonly affects children and adolescents.
First made-in-Canada CAR-T cell therapy for cancer shows promise in clinical trial
More than a dozen people with cancer who had exhausted all treatment options are alive and cancer-free today thanks to a pioneering Canadian clinical trial of a highly personalized kind of immunotherapy. The results, presented at the 2022 Cell Therapy Transplant Canada Conference, could open the door to a new era of made-in-Canada immunotherapies for cancer.
Terry Fox Laboratory celebrates 40 years
This year marks 40 years of science, discovery, innovation, collaboration and education at the Terry Fox Laboratory.
Dr. Aly Karsan receives UBC Killam Research Award
This prestigious award recognizes faculty who have a track record of outstanding research and scholarly contributions.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.